This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Jul 28;358(9278):329-30.

doi: 10.1016/s0140-6736(01)05503-9.

Measurement of atherosclerosis progression

A S Wierzbicki, M A Crook, T M Reynolds, D P Mikhalidis

PMID: 11501530
DOI: 10.1016/s0140-6736(01)05503-9

Comment

Measurement of atherosclerosis progression

A S Wierzbicki et al. Lancet. 2001.

. 2001 Jul 28;358(9278):329-30.

doi: 10.1016/s0140-6736(01)05503-9.

Authors

A S Wierzbicki, M A Crook, T M Reynolds, D P Mikhalidis

PMID: 11501530
DOI: 10.1016/s0140-6736(01)05503-9

No abstract available

PubMed Disclaimer

Comment on

Rigorous detection and vigorous treatment of familial hypercholesterolaemia.
Durrington PN. Durrington PN. Lancet. 2001 Feb 24;357(9256):574-5. doi: 10.1016/S0140-6736(00)04075-7. Lancet. 2001. PMID: 11558479 No abstract available.
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.
Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Smilde TJ, et al. Lancet. 2001 Feb 24;357(9256):577-81. doi: 10.1016/s0140-6736(00)04053-8. Lancet. 2001. PMID: 11558482 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science